At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02005 SSY GROUP
Trading 10-07 14:19:13
2.740
-0.015
-0.54%
High2.750Low2.700Vol280.00K
Open2.745D1 Closing2.755Amplitude1.81%
Mkt Cap7.90BTradable Cap7.90BTotal Shares2.89B
T/O764.05KT/O Rate0.01%Tradable Shares2.89B
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
SSY GROUP: China Pharmaceutical Company Limited Acquires Shares, Long Position Rises to 31.35%
HK Disclosure  ·  10-02
SSY GROUP: China Pharmaceutical Company Limited Acquires Shares, Long Position Rises to 31.35%
SSY Group Repurchases 6.55 Million Shares in September, Spending HKD 17.59 Million
Bulletin Express  ·  10-02
SSY Group Repurchases 6.55 Million Shares in September, Spending HKD 17.59 Million
SSY GROUP: China Pharmaceutical Company Limited Acquires Shares, Long Position Rises to 31.33%
HK Disclosure  ·  09-29
SSY GROUP: China Pharmaceutical Company Limited Acquires Shares, Long Position Rises to 31.33%
SSY Group: Jiguang Qu Acquires Shares, Long Position Rises to 43.44%
HK Disclosure  ·  09-29
SSY Group: Jiguang Qu Acquires Shares, Long Position Rises to 43.44%
SSY Group Announces Board Changes: Wu Hengyao Joins as Executive Director, Su Xuejun Steps Down
Bulletin Express  ·  09-28
SSY Group Announces Board Changes: Wu Hengyao Joins as Executive Director, Su Xuejun Steps Down
SSY Group Appoints Wu Hengyao as Executive Director
Stock News  ·  09-28
SSY Group Appoints Wu Hengyao as Executive Director
SSY Group - Appoints Wu Heng Yao as Executive Director Effective Sept 28, 2026
THOMSON REUTERS  ·  09-28
SSY Group - Appoints Wu Heng Yao as Executive Director Effective Sept 28, 2026
SSY GROUP: Jiguang Qu Acquires Shares, Long Position Rises to 43.39%
HK Disclosure  ·  09-25
SSY GROUP: Jiguang Qu Acquires Shares, Long Position Rises to 43.39%
SSY GROUP: China Pharmaceutical Company Limited Acquires Shares, Long Position Rises to 31.28%
HK Disclosure  ·  09-25
SSY GROUP: China Pharmaceutical Company Limited Acquires Shares, Long Position Rises to 31.28%
SSY Group Ltd.: Jiguang Qu Acquires Shares, Long Position Rises to 43.37%
HK Disclosure  ·  09-24
SSY Group Ltd.: Jiguang Qu Acquires Shares, Long Position Rises to 43.37%
SSY Group Allocates HK$1.955 Million to Repurchase 700,000 Shares on September 24
Stock News  ·  09-24
SSY Group Allocates HK$1.955 Million to Repurchase 700,000 Shares on September 24
SSY GROUP: Jiguang Qu Acquires Shares, Long Position Rises to 43.35%
HK Disclosure  ·  09-23
SSY GROUP: Jiguang Qu Acquires Shares, Long Position Rises to 43.35%
SSY GROUP: China Pharmaceutical Company Limited Acquires Shares, Long Position Rises to 31.26%
HK Disclosure  ·  09-23
SSY GROUP: China Pharmaceutical Company Limited Acquires Shares, Long Position Rises to 31.26%
SSY GROUP: Jiguang Qu Acquires Shares, Long Position Rises to 43.31%
HK Disclosure  ·  09-22
SSY GROUP: Jiguang Qu Acquires Shares, Long Position Rises to 43.31%
SSY Group Allocates HK$2.76 Million to Buy Back One Million Shares on September 22
Stock News  ·  09-22
SSY Group Allocates HK$2.76 Million to Buy Back One Million Shares on September 22
SSY Group: Jiguang Qu Acquires Shares, Long Position Rises to 43.27%
HK Disclosure  ·  09-21
SSY Group: Jiguang Qu Acquires Shares, Long Position Rises to 43.27%
SSY Group Executes HKD 2.20 Million Share Buyback, Reducing Free Float by 0.028%
Bulletin Express  ·  09-21
SSY Group Executes HKD 2.20 Million Share Buyback, Reducing Free Float by 0.028%
SSY Group (02005) Spends HK$2.2 Million on Share Buyback on September 21
Stock News  ·  09-21
SSY Group (02005) Spends HK$2.2 Million on Share Buyback on September 21
SSY GROUP: China Pharmaceutical Company Limited Acquires Shares, Long Position Rising to 31.22%
HK Disclosure  ·  09-18
SSY GROUP: China Pharmaceutical Company Limited Acquires Shares, Long Position Rising to 31.22%
SSY GROUP: Jiguang Qu Acquires Shares, Long Position Rises to 43.25%
HK Disclosure  ·  09-18
SSY GROUP: Jiguang Qu Acquires Shares, Long Position Rises to 43.25%

Introduction

Company Name.
SSY GROUP
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
SSY Group Ltd, formerly known as Lijun International Pharmaceutical Holding Co Ltd, is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Issue price:
--